Daily Newsview all

Thursday, August 25, 2016

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

By Todd Neale
Short- and long-term risks of dying are especially high in patients who receive one of the devices in a bail-out situation.
Thursday, August 25, 2016

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

By Michael O'Riordan
In tumultuous times, eastern Mediterranean countries, including Afghanistan, Iran, Iraq, Syria, and others, are seeing higher rates of CVD death.
Thursday, August 25, 2016

Depression Increases Risk of Acute MI by 30% in HIV-Positive Patients

By L.A. McKeown
A study of more than 26,000 US veterans highlights the need for awareness and prevention of CVD in those with HIV.
Wednesday, August 24, 2016

‘Shotgunning’ Approach Appears to Knock Down Readmissions After PCI

By Todd Neale
Implementation of a variety of initiatives was associated with a large reduction in return visits to a tertiary center over a 5-year period.
Wednesday, August 24, 2016

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

By Michael O'Riordan
Experts say there is a shortage of data to guide oral anticoagulation and antiplatelet therapy in this particularly high-risk patient population.
Wednesday, August 24, 2016

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

By Yael L. Maxwell
Despite widespread excitement, questions linger—mostly related to durability and complications—as transcatheter valves move into younger patients.
Tuesday, August 23, 2016

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

By L.A. McKeown
A subanalysis of the CoreValve High Risk trial supports emerging data and approvals for intermediate-risk TAVR.
Tuesday, August 23, 2016

Drug Company Payments to Physicians May Be Influencing Prescribing

By Todd Neale
Payments were associated with more days filled for marketed versus nonmarketed oral anticoagulants and noninsulin diabetes medications.
Tuesday, August 23, 2016

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

By Michael O'Riordan
Experts say imaging tests could potentially offer a disease-guided approach to tailoring the “impersonal” lipid-lowering guidelines.
Monday, August 22, 2016

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

By Yael L. Maxwell
Knowledge about variants linked to hypertrophic cardiomyopathy is constantly evolving, one expert says. Now a new study suggests some no longer hold up.

Conference Newsview all

Wednesday, August 24, 2016 | Source: ESC 2016

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

By Shelley Wood
(UPDATED) If you can pry yourself from the Trevi fountain, the jam-packed agenda offers 28 hotlines, new guidelines, and the city’s most famous neighbor.
Monday, June 20, 2016 | Source: TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

By Michael O'Riordan
Some key questions need to answered, not the least of which is the durability of the implanted valves.
Monday, June 20, 2016 | Source: TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

By Michael O'Riordan

Even among the most high-risk patients, some might be willing to undergo TAVR if it provides meaningful improvements in quality of life, say experts.

Monday, June 20, 2016 | Source: TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

By Shelley Wood
A second look at TAVR valve degeneration from the sites that did the earliest cases is stirring the debate over which definitions should be used.
Saturday, June 18, 2016 | Source: TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

By Michael O'Riordan
As in other reports, oral anticoagulation with warfarin appears to protect patients from developing subclinical leaflet thickening after TAVR and surgery.
Friday, June 17, 2016 | Source: TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

By Shelley Wood
Interventional cardiologists appear to have moved on from the see-it, fix-it approach of the past, but randomized clinical trial data are pending.
Friday, June 17, 2016 | Source: TVT 2016

What TAVR Needs Next . . . and What It’s Getting

By Shelley Wood

Amid talk of TAVR’s “relentless” march to low-risk patients at TVT 2016, experts unveiled the low-risk study designs and offered some notes of caution.

Thursday, June 16, 2016 | Source: TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

By Michael O'Riordan
In the single-center series, a simplified approach cut the average cost of TAVR by $10,000 without increasing the risk of death or stroke at 30 days.
Wednesday, June 08, 2016 | Source: EAS 2016

Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI

By Yael L. Maxwell
A single-center study suggests that physicians should look beyond LDL when monitoring cholesterol.
Tuesday, June 07, 2016 | Source: EAS 2016

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

By Yael L. Maxwell
Nonpharmaceutical strategies for modifying cardiometabolic risk should be discussed with patients, although a paucity of hard data plagues the field.